Nutrition Education and Diet Guidance While Using GLP-1 Medication
Part of Hormones & metabolism clinical trials.
This study teaches adults on GLP-1 medication (like Ozempic or Wegovy) how to eat better and lose weight using a smartphone app. Researchers want to see if personalized nutrition advice helps you get better results from your medication.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 65 years old
- You have a BMI of 30 or higher and/or type 2 diabetes (not type 1)
- You've been taking GLP-1 medication for at least 4 weeks
- You own a smartphone (iPhone or Android) with active internet service
- You are willing to eat fewer calories and modify your diet
- You don't have serious diabetes complications, active cancer treatment, or severe eating disorders
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This early-stage study looks at how genetic factors may change how people respond to a GLP-1 medicine (semaglutide). The goal is to learn who may benefit most and why, so future treatments can be better matched.
This study looks at whether exercise can help prevent muscle loss in people taking GLP-1 medications (like Wegovy, Ozempic, or Mounjaro) for weight loss. It may help you keep your muscles strong while you lose weight.
This trial tests whether using the Voy app can help people who are already taking a GLP-1 or GIP/GLP-1 weight loss medication lose more weight and improve their health. If you're eligible, the app will be added to your current treatment plan to see if it makes a difference.
This study tests whether switching to an oral weight-loss medication can help you keep off the weight you lost after stopping a GLP-1 injection like semaglutide or tirzepatide. You might qualify if you live in Massachusetts, are between 18 and 80, have a BMI of 30 or higher, lost at least 10% of your body weight on these injections, and are willing to be randomly assigned to a new treatment.
This study tests a 4-month digital program to help people taking a GLP-1 medication (like Ozempic or Wegovy) make healthy lifestyle changes while they continue the drug. Participants will get guidance and wear a Fitbit to track activity.
This study looks at how starting a GLP-1 medication (like Wegovy or Ozempic) changes your food choices and eating habits. It may help you understand if these medicines work for weight loss.
Hear when a new Obesity Type 2 Diabetes Mellitus trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.